Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fraser Wright

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Human Gene Therapy. Clinical Development|May 23, 2013
Advancing translational research through the NHLBI Gene Therapy Resource Program (GTRP)Cheryl L McDonald, Janet Benson, Kenneth Cornetta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responsesBernd Hauck, Samuel L Murphy, Peter H Smith, et al.
Human Gene Therapy. Clinical Development|June 19, 2015
Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced ArthritisLisette Bevaart, Caroline J Aalbers, Michel P M Vierboom, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapyHelen Lavender, Kevin Brady, Frances Burden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2012
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia BFederico Mingozzi, Yifeng Chen, Samuel L Murphy, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy. Methods & Clinical Development|December 27, 2014
SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATEWaldy San Sebastian, Adrian P Kells, John Bringas, et al.
The New England Journal of Medicine|March 27, 2013
Chimeric antigen receptor-modified T cells for acute lymphoid leukemiaStephan A Grupp, Michael Kalos, David Barrett, et al.
Blood|August 2, 2003
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIIICiaran D Scallan, Tongyao Liu, Amy E Parker, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Human Gene Therapy. Clinical Development|May 23, 2013
Advancing translational research through the NHLBI Gene Therapy Resource Program (GTRP)Cheryl L McDonald, Janet Benson, Kenneth Cornetta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responsesBernd Hauck, Samuel L Murphy, Peter H Smith, et al.
Human Gene Therapy. Clinical Development|June 19, 2015
Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced ArthritisLisette Bevaart, Caroline J Aalbers, Michel P M Vierboom, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapyHelen Lavender, Kevin Brady, Frances Burden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2012
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia BFederico Mingozzi, Yifeng Chen, Samuel L Murphy, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy. Methods & Clinical Development|December 27, 2014
SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATEWaldy San Sebastian, Adrian P Kells, John Bringas, et al.
The New England Journal of Medicine|March 27, 2013
Chimeric antigen receptor-modified T cells for acute lymphoid leukemiaStephan A Grupp, Michael Kalos, David Barrett, et al.
Blood|August 2, 2003
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIIICiaran D Scallan, Tongyao Liu, Amy E Parker, et al.
Pageof 7